Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
NCT ID: NCT02161211
Last Updated: 2023-02-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2014-07-31
2020-06-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format
NCT03300232
Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders
NCT03230006
Co-occurence of Mental Illness and Problematic Alcohol Use: an Internet-based Cognitive Behavior Therapy Intervention
NCT06789250
Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse
NCT00108407
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
NCT01243606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
De-coupling
Six sessions of CBT for anxiety-alcohol de-coupling
De-coupling
Six sessions of CBT for anxiety-alcohol de-coupling
Anxiety Reduction
Six sessions of CBT for anxiety reduction.
Anxiety Reduction
Six sessions of CBT for anxiety reduction.
Combined
Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.
Combined
Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
De-coupling
Six sessions of CBT for anxiety-alcohol de-coupling
Anxiety Reduction
Six sessions of CBT for anxiety reduction.
Combined
Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence
* alcohol use in the 30 days preceding the study
* ability to provide informed consent
* minimum of a sixth grade reading level (deemed necessary to complete study materials);
* willingness to provide contact information to confirm study follow-up appointments
* lives within proximity to the Twin Cities (e.g., within about an hour's drive) for the purpose attending follow-up visits
Exclusion Criteria
* cognitive or physical impairment that precludes study participation
* currently and seriously suicidal (i.e., plan and intent)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matt Kushner, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lodging Plus Program, Fairview Hospital
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSYCH-2016-22016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.